International Immunopharmacology

International Immunopharmacology英文簡介

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

? Agents that activate genes or modify transcription and translation within the immune response.

? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

? Production, function and regulation of cytokines and their receptors.

? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

International Immunopharmacology中文簡介

《International Immunopharmacology》是一本由ELSEVIER出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于2001年，刊期Monthly，該刊已被國際權(quán)威數(shù)據(jù)庫SCI、SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 2區(qū)，小類學(xué)科：藥學(xué) 2區(qū)；免疫學(xué) 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q1。該刊發(fā)文范圍涵蓋免疫學(xué)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國內(nèi)外免疫學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為5.714，平均審稿速度約2.7個(gè)月。

中科院分區(qū)最新升級版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	2區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué) IMMUNOLOGY 免疫學(xué)	2區(qū) 3區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學(xué)科	分區(qū)	影響因子
Q1	PHARMACOLOGY & PHARMACY	Q1	5.714
	IMMUNOLOGY	Q2

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
5.714	98	7.25%	88.27%	未開放	約2.7個(gè)月

IF值(影響因子)趨勢圖